These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The future of metabolic syndrome and cardiovascular disease prevention: polyhype or polyhope? Tales from the polyera. Franco OH; Karnik K; Bonneux L Horm Metab Res; 2007 Sep; 39(9):627-31. PubMed ID: 17846968 [TBL] [Abstract][Full Text] [Related]
14. The polypill to prevent cardiovascular disease: physicians' perspectives. Viera AJ Curr Opin Cardiol; 2011 Sep; 26(5):438-42. PubMed ID: 21730826 [TBL] [Abstract][Full Text] [Related]
15. [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus]. Ruiz J; Egli M Rev Med Suisse; 2006 May; 2(68):1480-2, 1484-5. PubMed ID: 16783994 [TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular polypill in high risk patients]. Lafeber M; Spiering W; Bots ML; de Valk V; Visseren FL; Grobbee DE Ned Tijdschr Geneeskd; 2011; 155(44):A3070. PubMed ID: 22067559 [TBL] [Abstract][Full Text] [Related]
17. [The polypill: not an effective strategy for reduction of cardiovascular disease]. Westerweel PE; van Wijk JP; Verhaar MC Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291 [TBL] [Abstract][Full Text] [Related]
18. [The polypill--an alternative concept in cardiovascular prophylaxis]. Sandli OK; Spigset O; Slørdal L Tidsskr Nor Laegeforen; 2014 Mar; 134(6):632-4. PubMed ID: 24670513 [No Abstract] [Full Text] [Related]
19. The polypill in the primary prevention of cardiovascular disease. Wald DS; Wald NJ Fundam Clin Pharmacol; 2010 Feb; 24(1):29-35. PubMed ID: 20002198 [TBL] [Abstract][Full Text] [Related]